KIT and leukemia: Gain-of-function KIT mutations, resulting in constitutive tyrosine kinase activity, are significantly enriched in patients with core binding factor leukemia [85,86], and these mutations are associated in t(8;21)-related leukemia with unfavorable outcome [87,88].